MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma
Clinical trial NCT06557330 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06557330
- Sponsor
- Fox Chase Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2027-09-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.